Skip NavigationSkip to Content

The Effect of Preanalytical Conditions on Blood-Based Inflammation Biomarkers

  1. Author:
    O'Donnell, Thomas [ORCID]
    Weinstein, Stephanie
    Yano, Yukiko
    Albert, Paul
    Black, Amanda
    Brotzman, Michelle
    Diaz-Mayoral,Norma
    Shreves, Alaina
    Gerlanc, Nicole
    Wyatt, Kathleen
    Gaudet, Mia M
    Abnet, Christian
    Wentzensen, Nicolas
  2. Author Address

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850, United States., BioProcessing Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21701, United States., Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.,
    1. Year: 2025
    2. Date: Jun 18
    3. Epub Date: 2025 06 18
  1. Journal: Journal of Proteome Research
  2. Type of Article: Article
  1. Abstract:

    Blood-based inflammation biomarkers have potential for diagnostic, prognostic, and predictive testing, but preanalytical processing conditions can affect biomarker levels. We investigated how needle-to-freezer time, centrifugation timing, and tube types influence inflammation biomarkers. Twenty subjects donated 21 different blood samples in collection tubes, including plasma and serum types. Ninety-two biomarkers from each sample were analyzed using the Olink Target 96 Inflammation panel. We compared biomarker concentrations across different preanalytical variables to a reference standard tube. Intraclass, Pearson, and Spearman 39;s correlation coefficients were calculated. We also assessed the impact of these conditions on age-related associations with biomarkers. Across the preprocessing protocol/blood matrix combinations, 38%-83%, 50%-87%, and 47%-79% of proteins showed good to excellent correlations in intraclass, Pearson, and Spearman analyses, respectively. Eighteen proteins differed by >0.5 NPX units between test and reference protocols. Among 30 comparisons of age-related biomarker associations showing p = 0.05 at baseline, 12 (40%) maintained a p = 0.05 across all needle-to-freezer times. Many proteins in the Olink Target 96 Inflammation panel exhibited robust stability across various preanalytical conditions, indicating that blood-based inflammation biomarkers are suitable for testing across different blood specimen types. Further studies are needed to evaluate the impact of long-term storage.

    See More

External Sources

  1. DOI: 10.1021/acs.jproteome.5c00225
  2. PMID: 40531187

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel